|
Shareholder Questions
Relationships with legal counsel
—
Does the
company have an in-house legal function?
—
Which outside
firms are used to provide general legal advice and SEC counsel, if separate?
Are any members of these firms also directors of the company?
—
Does the board
have the ability to retain independent legal counsel for potential conflicts
of interest on matters that management has a personal interest in, such as a
retirement plan for senior executives?
—
Do both the
in-house and outside counsel have direct access to the board?
—
Have any
in-house or outside attorneys resigned or been terminated by the company
during the last year? If so, what were the circumstances?
Compliance with laws, regulations
and publicly known problems
—
How does the
board monitor the company’s compliance with legal requirements?
—
Do the
directors feel they are adequately apprised of changes in laws and
regulations, including federal securities laws, federal sentencing
guidelines, stock exchange governance requirements, and state laws?
—
Do the directors
feel they are adequately apprised of relevant court decisions?
—
Are
the company’s attorneys instructed to report any illegal acts to the board or
the audit committee on a timely basis?
—
Has the board
discussed any problems that were cited in security analysts’ reports, press
articles, or other media during the past year? What actions, if any, were
taken in response to these matters?
—
Has the company
had any difficulty maintaining its stock exchange listing?
—
Is the company
in compliance with immigration rules and regulations? How is this compliance
monitored?
—
Does management
have adequate policies and procedures in place to ensure that information
collected about the company’s customers, vendors, or other trading partners
remains private?
—
When is the last
time the directors participated in compliance training?
Prevention
of problems and penalties
—
Has the company
taken steps to prevent fraudulent financial reporting or other corporate
wrongdoing?
—
Does the board
regularly review to ensure the CEO and senior management are setting a “tone
at the top” that stresses legal compliance?
—
Has the company
taken all necessary steps to minimize the fines or sentences that might be
imposed in response to fraudulent financial reporting or other corporate
wrongdoing?
—
How does
management ensure that no illegal immigrants are employed by the company or
its contractors?
—
Has the company
considered including alternative dispute resolution clauses in contracts and
other agreements with its customers, suppliers, and employees?
—
Does the
company conduct periodic assessments of the strength of its patent
portfolios?
—
Has the company
taken appropriate legal actions to protect its patents, trademarks, and other
proprietary property?
—
How does the
company protect the integrity of existing patents, technology, and
intellectual property overseas?
—
Is the company
prepared for patent or anti-trust challenges?
—
Does the
company have a “crisis plan” to deal with big mistakes and crises such as
investigations, restatements, or research reports that get negative press?
Investigations and pending
litigation
—
Is the company
under investigation by any Federal or state regulatory agency? What issues
are involved, and how will the issues be resolved? When will the
investigation end?
—
Has the SEC or
any other regulatory body investigated the company or its management or
questioned any of its reporting practices? What is the status of the matter,
and what is management doing to resolve the issues?
—
If the company
operates in a regulated industry, has it been subject to a regulatory
examination during the past year? What were the results of the examination?
How is management planning to address any problems identified?
—
Does
the company have a policy of self-reporting and cooperating, should an SEC or
other regulatory agency initiate an investigation?
—
Were any of the
company’s products taken off the market due to decisions by the FDA or other
government agencies? What is the impact on revenues and earnings?
—
Is any
government agency investigating the company’s importing and exporting
practices? If so, what is the status of the investigation?
—
What matters
are currently being litigated? What is the likely outcome?
—
Will damages,
if any, from pending litigation be covered by insurance? Are there any issues
about insurance coverage?
—
Has the company
adequately reserved for liabilities from pending litigation?
—
If the company
is a plaintiff in any actions, what are the damages claimed and how long will
it take to resolve the suits?
—
What expenses
were incurred for legal fees, and what amounts were paid in settlements this
year and last year? What legal services were provided and by whom?
Other legislative and regulatory
matters
—
Is the company
having difficulty obtaining general liability insurance or insurance for directors
and officers?
—
How much is it
costing the company to comply with Section 404 of the Sarbanes-Oxley Act of
2002?
—
In light of the
costs of the Sarbanes-Oxley Act, would the company consider plans to
deregister or go private? If so, how would current shareholders be assured
that they will receive a fair price?
—
How will the
company be affected by the proposed changes in funding requirements for
pension plans?
—
Why has it
taken so long for the company’s patent applications to be approved? Why does
it take so long for FDA or other approvals to be obtained? What is the likely
impact on sales and earnings if they are (or are not) obtained?
—
Does the
company employ lobbyists to influence Congressional action? Which matters are
of interest to the company and how much is being spent on lobbying efforts?
—
Did the company
adopt or amend any retirement plans this year? What were the costs or
savings?
—
Does the
company limit the amount of its own stock that may be held in retirement
plans?
|